Literature DB >> 30888066

Functions and roles of long noncoding RNA in cholangiocarcinoma.

Jinglin Li1, Lining Huang1, Zhenglong Li1, Xiangyu Zhong1, Sheng Tai1, Xingming Jiang1, Yunfu Cui1.   

Abstract

Cholangiocarcinoma (CCA) is one of the most fatal cancers in humans, with a gradually increasing incidence worldwide. The efficient diagnostic and therapeutic measures for CCA to reduce mortality are urgently needed. Long noncoding RNAs (lncRNAs) may provide the potential diagnostic and therapeutic option for suppressing the CCA development. LncRNAs are a type of non-protein-coding RNAs, which are larger than 200 nucleotides in length. Increasing evidence reveals that lncRNAs exhibit critical roles in the carcinogenesis and development of CCA. Deregulation of lncRNAs impacts the proliferation, migration, invasion, and antiapoptosis of CCA cells by multiple sophisticated mechanisms. Consequently, lncRNAs likely represent promising biomarkers or intervention targets of CCA. In this review, we summarize current studies regarding the biological functions and regulatory mechanisms of diverse lncRNAs in CCA.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarker; cholangiocarcinoma; lncRNA; mechanism; prognosis

Mesh:

Substances:

Year:  2019        PMID: 30888066     DOI: 10.1002/jcp.28470

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

Review 1.  Cholangiocarcinoma: novel therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Domenico Alvaro; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2020-02-26       Impact factor: 6.902

Review 2.  Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

Authors:  Fang Bao; Jiayue Liu; Haiyang Chen; Lu Miao; Zhaochao Xu; Guixin Zhang
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

3.  YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.

Authors:  Jinglin Li; Xingming Jiang; Yi Xu; Pengcheng Kang; Peng Huang; Nanfeng Meng; Hang Wang; Wangyang Zheng; Hao Wang; Zhidong Wang; Xiangyu Zhong; Yunfu Cui
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

4.  Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors.

Authors:  Olga Y Burenina; Natalia L Lazarevich; Inna F Kustova; Daria A Shavochkina; Ekaterina A Moroz; Nikolay E Kudashkin; Yuriy I Patyutko; Alexey V Metelin; Eduard F Kim; Dmitry A Skvortsov; Timofei S Zatsepin; Maria P Rubtsova; Olga A Dontsova
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-12       Impact factor: 4.553

Review 5.  Current challenges to underpinning the genetic basis for cholangiocarcinoma.

Authors:  Antonio Cigliano; Xin Chen; Diego F Calvisi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-04-23       Impact factor: 3.869

Review 6.  Molecular heterogeneity in intrahepatic cholangiocarcinoma.

Authors:  Keun Soo Ahn; Koo Jeong Kang
Journal:  World J Hepatol       Date:  2020-12-27

7.  Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.

Authors:  Jinglin Li; Canghai Guan; Zengtao Hu; Lang Liu; Zhilei Su; Pengcheng Kang; Xingming Jiang; Yunfu Cui
Journal:  Hum Cell       Date:  2020-10-10       Impact factor: 4.174

8.  AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.

Authors:  Xingming Jiang; Jinglin Li; Weina Wang; Zengtao Hu; Canghai Guan; Yuqiao Zhao; Wenzhi Li; Yunfu Cui
Journal:  Aging (Albany NY)       Date:  2020-01-24       Impact factor: 5.682

9.  Long noncoding RNA SNHG6 promotes proliferation and angiogenesis of cholangiocarcinoma cells through sponging miR-101-3p and activation of E2F8.

Authors:  Huishan Wang; Li Wang; Lingyu Tang; Jing Luo; Hao Ji; Wen Zhang; Jian Zhou; Quanpeng Li; Lin Miao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

10.  SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.

Authors:  Jinglin Li; Xingming Jiang; Zhenglong Li; Lining Huang; Daolin Ji; Liang Yu; Yongxu Zhou; Yunfu Cui
Journal:  Aging (Albany NY)       Date:  2020-08-28       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.